查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2048372

顯微切片機市場－全球產業規模、佔有率、趨勢、機會、預測：按產品、技術、地區和競爭對手分類，2021-2031年

Microtome Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product (Microtome Devices, Accessories), By Technology (Fully Automated, Semi-Automated, Manual) Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 185 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球切片機市場預計將從 2025 年的 1.3611 億美元成長到 2031 年的 1.8842 億美元，複合年成長率為 5.57%。

該市場專注於組織病理學中必不可少的精密儀器，這些儀器專為製備用於顯微鏡檢查的超薄組織切片而設計。推動這一成長的關鍵因素包括全球慢性病（尤其是癌症）發病率的上升，導致為準確診斷而進行的切片檢查增加；以及老年人口的不斷成長，持續推高臨床和研究環境中對診斷服務和可靠組織切片設備的需求。儘管成長強勁，但市場擴張仍面臨一個重大限制：全球範圍內熟練的病理學家和技術人員短缺。這種短缺限制了醫療機構高效處理日益成長的檢體量的能力，儘管對高效組織處理的需求仍然非常高，但診斷中心的運作能力卻受到限制。近期疾病負擔統計數據進一步凸顯了對高容量解決方案的迫切需求。例如，美國癌症協會預測，到2025年，美國將新增約2,041,910例癌症病例，凸顯了病理檢查室面臨的日益成長的壓力。

市場概覽
預測期 2027-2031
市場規模：2025年 1.3611億美元
市場規模：2031年 1.8842億美元
複合年成長率：2026-2031年 5.57%
成長最快的細分市場 配件
最大的市場 北美洲

市場促進因素

自動化切片技術的快速發展正從根本上改變市場格局，它不僅消除了實驗室的一大瓶頸，還顯著提高了組織切片的精確度。將自動化引入組織切片工作流程，可大幅降低傳統方法中常見的操作誤差，從而提高用於診斷和研究的切片的一致性和品質。徠卡顯微系統公司於2024年3月推出的UC Enuity便是此一趨勢的典型例證。這款自動化超薄切片設備旨在透過其自動修整功能確保高品質的切片結果。對於希望維持高處理能力並緩解熟練技術人員短缺問題的檢查室而言，此類創新至關重要，從而確保切片設備市場能夠持續滿足現代病理學的需求。同時，藥物研發的強勁成長也是市場擴張的主要驅動力，這主要得益於複雜生物製藥和個人化療法開發所需的大量組織分析。切片機在藥物研發的臨床前階段不可或缺，用於製備評估藥物療效和毒性的檢體。目前正在研發的潛在治療方法數量眾多，這推動了相關研究活動的蓬勃發展。例如，國際藥品製造商協會聯合會（IFPMA）報告稱，截至2024年10月，全球將有超過12,700種藥物處於不同的研發階段。此外，疾病負擔依然沉重，世界衛生組織（WHO）報告稱，2022年全球新增肺癌病例達250萬例，凸顯了嚴謹的組織學檢查的重要性。這些因素共同推動了對可靠的切片解決方案的需求。

市場挑戰

熟練病理學家和技術人員的短缺正在嚴重阻礙診斷流程，並成為全球切片機市場成長的主要限制因素。儘管慢性病發病率上升導致切片檢查需求增加，但醫療機構卻因無法獲得足夠的合格人員而受到限制，這直接阻礙了其運作能力。由於切片機通常需要訓練有素的專家進行手動操作，缺乏足夠的人員來處理和解讀檢體阻礙了實驗室擴展服務，檢查室中心被迫優先考慮人員穩定而非資本投資，這常常導致新型組織切片設備的引進被推遲。近期的數據有力地印證了這項營運限制，凸顯了人員短缺的嚴重性。英國英國病理學院的一項調查顯示，78%的病理學家認為，到2025年，目前的人員配備水準將不足以滿足不斷成長的臨床需求。這種嚴重的供需失衡直接阻礙了市場採用新技術的能力。由於人力資源限制，檢查室難以處理目前的病例，對額外切片機的需求受到抑制，儘管對疾病診斷的潛在需求不斷增加，但市場潛力實際上已達到飽和。

市場趨勢

切片技術和數位病理學的融合正在積極地重新定義切片標準，以滿足全切片成像 (WSI) 的嚴格要求。由於數位掃描器需要極其平整的組織條帶才能保持穩定的焦點，製造商被迫開發具有更高垂直穩定性和自動厚度調節功能的切片機。這種融合也高度重視資料完整性，透過將實體切片與其對應的虛擬切片精確鏈接，確保數位化工作流程中控制鏈的無縫銜接。 2025 年 12 月，徠卡生物系統公司發布了 Aperio GT 180 DX 掃描儀和 Aperio iQC DX 軟體，旨在滿足臨床數位病理學的品管和處理需求，這清楚地展現了業界的這一重大轉變。這預示著一個高度依賴精密切片設備的成熟生態系統的到來。同時，術中快速診斷對冷凍切片機的需求也在不斷成長，這主要是由於手術過程中需要立即確認切緣。外科醫生在諸如莫爾斯手術等手術中高度依賴冷凍切片檢查，因此需要能夠提供快速冷凍循環和精確溫度控制的設備，以防止可能干擾診斷的偽影。由於需要即時處理的皮膚惡性腫瘤病例數量不斷增加，這種需求也不斷成長。例如，皮膚癌基金會預測，到2025年1月，美國將新增約212,200例黑色素瘤病例，凸顯了高性能冷凍儀在確保及時、準確的手術結果方面發揮的關鍵作用。

目錄

第1章概述

第2章：調查方法

第3章執行摘要

第4章：客戶心聲

第5章：全球顯微切片機市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 產品分解（切片機主機、配件）
    • 按技術（全自動、半自動、手動）
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

第6章：北美顯微切片機市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國別分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲微切片機市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國別分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太地區微型切片機市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國別分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：中東與非洲微切片機市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東與非洲：國別分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美洲微切片機市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國別分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進因素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 近期趨勢

第13章：全球顯微切片機市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的議價能力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • Diapath SPA
  • Leica Biosystems Nussloch GmbH
  • Sakura Finetek Europe BV
  • MEDITE GmbH
  • SLEE medical GmbH
  • Boeckeler Instruments Inc.
  • Thermo Fisher Scientific Inc.
  • SM Scientific Instruments Pvt. Ltd.
  • AGD Biomedicals Pvt. Ltd.
  • Amos Scientific Pvt. Ltd.

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 20619

The Global Microtome Market is projected to expand from USD 136.11 Million in 2025 to USD 188.42 Million by 2031, demonstrating a compound annual growth rate (CAGR) of 5.57%. This market encompasses precision instruments essential for histopathology, specifically designed to prepare extremely thin tissue sections for microscopic analysis. Key drivers of this growth include the rising worldwide incidence of chronic diseases, particularly cancer, which necessitates a greater volume of biopsy procedures for accurate diagnosis, alongside an expanding geriatric population that consistently fuels demand for diagnostic services and reliable tissue sectioning equipment in clinical and research settings. Despite this robust growth, market expansion faces a significant constraint from the global scarcity of skilled pathologists and technicians. This workforce deficit limits the capacity of healthcare facilities to efficiently process an increasing volume of samples, creating a bottleneck in operational throughput for diagnostic centers, even as the need for effective tissue processing remains critical. The urgency for high-capacity solutions is further underscored by recent disease burden statistics, such as the American Cancer Society's projection of approximately 2,041,910 new cancer cases in the United States in 2025, which highlights the intensifying pressure on pathology laboratories.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 136.11 Million
Market Size 2031USD 188.42 Million
CAGR 2026-20315.57%
Fastest Growing SegmentAccessories
Largest MarketNorth America

Market Driver

Rapid technological advancements in automated microtomy are fundamentally transforming the market by addressing critical laboratory bottlenecks and significantly enhancing sectioning precision. The integration of automation into tissue sectioning workflows substantially reduces the manual variability often associated with traditional methods, thereby improving the consistency and quality of slides used for both diagnosis and research. A notable example of this trend is the launch of the UC Enuity by Leica Microsystems in March 2024, an automated ultramicrotome designed to ensure high-quality results through its automated trimming features. Such innovations are vital for laboratories aiming to maintain high throughput and mitigate the impact of skilled technician shortages, ensuring that the microtome market continues to align with modern pathology needs. Concurrently, the robust growth in pharmaceutical research and development acts as a primary catalyst for market expansion, driven by the extensive tissue analysis required for developing complex biologics and personalized therapies. Microtomes are indispensable in the preclinical phases of drug development for preparing specimens to evaluate drug efficacy and toxicity. This surge in research activity is substantiated by the volume of potential treatments currently in development; for instance, the International Federation of Pharmaceutical Manufacturers and Associations reported over 12,700 medicines in various stages of global development in October 2024. Furthermore, the persistent burden of diseases, with the World Health Organization reporting 2.5 million new lung cancer cases worldwide in 2022, necessitates rigorous histological examination, reinforcing the demand for reliable microtomy solutions.

Market Challenge

The shortage of skilled pathologists and technicians poses a significant restriction on the growth of the Global Microtome Market by creating a critical bottleneck within diagnostic workflows. Even as rising chronic disease rates drive a greater need for biopsy volumes, healthcare facilities are constrained by their inability to recruit sufficient qualified personnel, which directly limits their operational capacity. Since microtomes often require manual operation by trained professionals, a lack of adequate staff to process and interpret samples prevents laboratories from scaling their services, frequently leading diagnostic centers to prioritize labor stability over capital expansion and often delaying the procurement of new tissue sectioning devices. This operational constraint is strongly supported by recent data highlighting the severity of the workforce deficit. According to the Royal College of Pathologists in 2025, 78% of pathologists reported that existing staffing levels were insufficient to meet escalating clinical demand. This significant disparity directly impedes the market's capacity to adopt new technology, as laboratories struggling with current caseloads due to limited human resources experience stifled demand for additional microtomes, effectively capping market potential despite the underlying and growing need for disease diagnosis.

Market Trends

The convergence of microtomy with digital pathology is actively redefining sectioning standards to meet the stringent requirements of Whole Slide Imaging (WSI). Digital scanners demand exceptionally flat tissue ribbons to maintain consistent focus, compelling manufacturers to engineer microtomes with enhanced vertical stability and automated thickness calibration capabilities. This integration also places a high priority on data integrity, ensuring a seamless chain-of-custody within the digitized workflow by precisely linking physical sections to their corresponding virtual slides. This significant industry shift was exemplified when, in December 2025, Leica Biosystems launched the Aperio GT 180 DX scanner and Aperio iQC DX software, explicitly designed to support the quality control and throughput demands of clinical digital pathology, signaling a mature ecosystem that critically depends on precision sectioning equipment. Simultaneously, there is a rising preference for cryostats in rapid intraoperative diagnostics, primarily driven by the critical need for immediate surgical margin verification during procedures. Surgeons heavily rely on frozen section analysis in operations such as Mohs surgery, necessitating equipment that provides rapid freezing cycles and precise temperature control to prevent artifacts that could compromise diagnosis. This demand is escalating due to the increasing volume of skin malignancies requiring real-time management; for instance, the Skin Cancer Foundation projected an estimated 212,200 new cases of melanoma to be diagnosed in the United States in January 2025, underscoring the vital role of high-performance cryostats in ensuring timely and accurate surgical outcomes.

Key Market Players

  • Diapath S.P.A.
  • Leica Biosystems Nussloch GmbH
  • Sakura Finetek Europe B.V.
  • MEDITE GmbH
  • SLEE medical GmbH
  • Boeckeler Instruments Inc.
  • Thermo Fisher Scientific Inc.
  • S.M. Scientific Instruments Pvt. Ltd.
  • AGD Biomedicals Pvt. Ltd.
  • Amos Scientific Pvt. Ltd.

Report Scope

In this report, the Global Microtome Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Microtome Market, By Product

  • Microtome Devices
  • Accessories

Microtome Market, By Technology

  • Fully Automated
  • Semi-Automated
  • Manual

Microtome Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Microtome Market.

Available Customizations:

Global Microtome Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Microtome Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product (Microtome Devices, Accessories)
    • 5.2.2. By Technology (Fully Automated, Semi-Automated, Manual)
    • 5.2.3. By Region
    • 5.2.4. By Company (2025)
  • 5.3. Market Map

6. North America Microtome Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product
    • 6.2.2. By Technology
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Microtome Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product
        • 6.3.1.2.2. By Technology
    • 6.3.2. Canada Microtome Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product
        • 6.3.2.2.2. By Technology
    • 6.3.3. Mexico Microtome Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product
        • 6.3.3.2.2. By Technology

7. Europe Microtome Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product
    • 7.2.2. By Technology
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Microtome Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product
        • 7.3.1.2.2. By Technology
    • 7.3.2. France Microtome Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product
        • 7.3.2.2.2. By Technology
    • 7.3.3. United Kingdom Microtome Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product
        • 7.3.3.2.2. By Technology
    • 7.3.4. Italy Microtome Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product
        • 7.3.4.2.2. By Technology
    • 7.3.5. Spain Microtome Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product
        • 7.3.5.2.2. By Technology

8. Asia Pacific Microtome Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product
    • 8.2.2. By Technology
    • 8.2.3. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Microtome Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product
        • 8.3.1.2.2. By Technology
    • 8.3.2. India Microtome Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product
        • 8.3.2.2.2. By Technology
    • 8.3.3. Japan Microtome Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product
        • 8.3.3.2.2. By Technology
    • 8.3.4. South Korea Microtome Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product
        • 8.3.4.2.2. By Technology
    • 8.3.5. Australia Microtome Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product
        • 8.3.5.2.2. By Technology

9. Middle East & Africa Microtome Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product
    • 9.2.2. By Technology
    • 9.2.3. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Microtome Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product
        • 9.3.1.2.2. By Technology
    • 9.3.2. UAE Microtome Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product
        • 9.3.2.2.2. By Technology
    • 9.3.3. South Africa Microtome Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product
        • 9.3.3.2.2. By Technology

10. South America Microtome Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product
    • 10.2.2. By Technology
    • 10.2.3. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Microtome Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product
        • 10.3.1.2.2. By Technology
    • 10.3.2. Colombia Microtome Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product
        • 10.3.2.2.2. By Technology
    • 10.3.3. Argentina Microtome Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product
        • 10.3.3.2.2. By Technology

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Microtome Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Diapath S.P.A.
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Leica Biosystems Nussloch GmbH
  • 15.3. Sakura Finetek Europe B.V.
  • 15.4. MEDITE GmbH
  • 15.5. SLEE medical GmbH
  • 15.6. Boeckeler Instruments Inc.
  • 15.7. Thermo Fisher Scientific Inc.
  • 15.8. S.M. Scientific Instruments Pvt. Ltd.
  • 15.9. AGD Biomedicals Pvt. Ltd.
  • 15.10. Amos Scientific Pvt. Ltd.

16. Strategic Recommendations

17. About Us & Disclaimer